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Inhibition of the deubiquitinase USP8 corrects a
Drosophila PINK1 model of mitochondria dysfunction
Sophia von Stockum1, Alvaro Sanchez-Martinez2 , Samantha Corra`3,4, Joy Chakraborty3, Elena Marchesan1,
Lisa Locatello3 , Caterina Da Rè3,4, Paola Cusumano3,4, Federico Caicci3, Vanni Ferrari3, Rodolfo Costa3,4 ,
Luigi Bubacco3, Maria Berica Rasotto3, Ildiko Szabo3, Alexander J Whitworth2 , Luca Scorrano3,5, Elena Ziviani1,3
Aberrant mitochondrial dynamics disrupts mitochondrial function
and contributes to disease conditions. A targeted RNA interference
screen for deubiquitinating enzymes (DUBs) affecting protein
levels of multifunctional mitochondrial fusion protein Mitofusin
(MFN) identiﬁed USP8 prominently inﬂuencing MFN levels. Ge-
netic and pharmacological inhibition of USP8 normalized the
elevated MFN protein levels observed in PINK1 and Parkin-
deﬁcient models. This correlated with improved mitochondrial
function, locomotor performance and life span, and prevented
dopaminergic neurons loss in Drosophila PINK1 KO ﬂies. We
identiﬁed a novel target antagonizing pathologically elevated
MFN levels, mitochondrial dysfunction, and dopaminergic neu-
ron loss of a Drosophila model of mitochondrial dysfunction.
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Introduction
Mitochondria dysfunction plays critical role in neurodegenerative
conditions affecting the elderly, such as Parkinson’s disease (PD)
(Moore et al, 2005; Bueler, 2009; Vives-Bauza et al, 2010a; Ryan
et al, 2015). Mitochondria function directly correlates with
mitochondria dynamics and balanced remodeling of the
mitochondrial network through ﬁssion and fusion events to
control mitochondria shape and ultrastucture. Intuitively,
fusion maintains the mitochondrial network and allows
intermixing of matrix contents, such as mtDNA and metabolites;
ﬁssion is needed to populate new cells with new mitochondria
(Twig et al, 2008b; Gomes & Scorrano, 2008; Malena et al, 2009) and
plays a substantial role in the mitochondria quality control. A key
aspect of mitochondrial quality control is a well-characterized
process called mitophagy that segregates and selectively elimi-
nates damaged mitochondria via autophagy (Twig et al, 2008a;
Twig & Shirihai, 2011). During stress-induced mitophagy, the
cytoplasmic protein Parkin, mutated in familial PD and encoding
an E3 ubiquitin ligase (Shimura et al, 2000), translocates in a
PINK1-dependent manner to dysfunctional mitochondria
(Narendra et al, 2008; Vives-Bauza et al, 2010b; Ziviani et al, 2010).
In this process, kinase PINK1, also mutated in familial PD (Silvestri
et al, 2005), phosphorylates Parkin (Sha et al, 2010), its targets
(Wang et al, 2011; Chen & Dorn, 2013), and ubiquitin itself (Koyano
et al, 2014) promoting Parkin translocation (Narendra et al, 2010;
Ziviani et al, 2010) and Parkin activity (Lazarou et al, 2013; Koyano
et al, 2014; Zhang et al, 2014). On depolarized mitochondria, Parkin
ubiquitinates the mitochondrial pro-fusion protein Mitofusin
(MFN) (Gegg et al, 2010; Poole et al, 2010; Tanaka et al, 2010; Ziviani
et al, 2010; Sarraf et al, 2013) leading to p97/VCP–mediated ret-
rotranslocation and proteosomal degradation (Tanaka et al, 2010).
In addition, Parkin ubiquitinates the mitochondrial protein
translocase TOM20, mitochondrial VDAC/Porin and Fis1 (Sarraf et
al, 2013), and it also promotes the degradation of Miro (Wang et al,
2011), a protein that couples mitochondria to microtubules. Se-
lected mitochondria are, therefore, deprived of their pro-fusion
protein MFN, isolating them from the mitochondrial network,
before degradation via autophagy. This mechanism is consistent
with observations showing that mitochondria cluster around the
perinuclear area (Vives-Bauza et al, 2010b) and fragment before
mitophagy (Twig et al, 2008a; Poole et al, 2008). Genetic studies in
Drosophila showed that down-regulation of MFN or promotion of
mitochondrial ﬁssion by expressing pro-ﬁssion protein DRP1
rescues Parkin KO phenotypes, and those of kinase PINK1 (Deng et
al, 2008; Poole et al, 2008), which acts upstream of Parkin (Clark et
al, 2006; Park et al, 2006; Yang et al, 2006). This genetic interaction
can be in part explained biochemically by the fact that Parkin
ubiquitinates MFN to control its steady-state levels (Gegg et al,
2010; Tanaka et al, 2010; Ziviani et al, 2010; Rakovic et al, 2011) that
are elevated in Parkin and PINK1 KO models (Ziviani et al, 2010).
Thus, interventions that restore MFN levels can ameliorate Parkin
and PINK1 phenotypes, presumably by impinging on the numerous
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MFN functions that in the fruit ﬂy include both promotion of fusion
and ER–mitochondria crosstalk (Debattisti et al, 2014).
To identify other mechanisms regulating MFN levels, we per-
formed an RNA interference screen for deubiquitinating enzymes
(DUBs) that affect steady-state levels of MFN. DUBs participate in
important reversible signaling pathways (Salmena & Pandolﬁ, 2007)
and are attractive druggable candidates (Hussain et al, 2009;
Colland, 2010). We identiﬁed USP8, an evolutionary conserved DUB
whose down-regulation correlates with decreasedMFN levels. USP8
has previously been linked to PINK1/Parkin–dependent mitophagy
in cell culture and under intoxicating conditions (Durcan et al, 2014),
but no in vivo studies have been reported. Here, we demonstrate
that in vivo under basal conditions, genetic and pharmacological
inhibition of USP8 ameliorates Drosophila phenotypes deriving
from loss of function of PINK1 and Parkin.
Results
A targeted siRNA screening identiﬁes DUBs affecting MFN protein
levels
Steady-state levels of MFN protein in Drosophila PINK1 or Parkin KO
background are increased (Ziviani et al, 2010), and interventions
that decrease MFN levels can ameliorate Drosophila PINK1 and
Parkin phenotypes (Celardo et al, 2016; Deng et al, 2008; Poole et al,
2008). Given the importance of MFN in inter-organellar commu-
nication (Cosson et al, 2012; de Brito & Scorrano, 2008; Filadi et al,
2015) and mitophagy (Chen & Dorn, 2013), we set out to identify
regulators of its steady-state levels. We designed an unbiased loss-
of-function screen using dsRNA to inhibit the expression of 35
known or predicted ﬂy DUBs. Fly DUBs were identiﬁed by domain
similarity and based on the list of 79 human DUBs (Dupont et al,
2009) (Table 1). We transiently expressed ﬂag-tagged MFN in S2R+
cells to mimic pathologically elevated MFN and down-regulated
each of the 35 DUBs. To assess the effect of DUB silencing on steady-
state MFN levels, we performed Western blotting analysis on cell
lysates and quantiﬁed the levels of unmodiﬁed MFN normalized for
the loading control and expressed it as fold change (Fig 1A). Flag-
tagged MFN exhibited mitochondrial subcellular localization, and
its expression in S2R+ cells resulted in an elongated mitochondrial
network (Fig S1A). We identiﬁed two DUBs whose down-regulation
resulted in decreased MFN levels (CG5798/USP8 and CG5384/USP14)
and two DUBs, whose down-regulation resulted in increased MFN
levels (CG5505/USP36, CG2904/Echinus) (Fig 1B). Down-regulation of
Parkin or PINK1 increased MFN levels, as previously described
(Tanaka et al, 2010; Ziviani et al, 2010). Of the two DUBs causing
decreased MFN levels, USP8 was the highest scoring hit that de-
creasedMFN levels (Fig 1B). USP8 interactswithmany substrates such
as the epidermal growth factor receptor, an essential regulator of
proliferation anddifferentiation, and regulates endosomal trafﬁcking
by ubiquitin-mediated sorting of the endocytosed cargoes (Mizuno
et al, 2005; Row et al, 2006; Williams & Urbe, 2007). Moreover, USP8
knockdown protects from α-synuclein–induced locomotor deﬁcits
and cell loss in an α-synuclein ﬂy model of PD (Alexopoulou et al,
2016). It was also shown that USP8 regulates induced mitophagy by
controlling Parkin recruitment to depolarized mitochondria after
CCCP treatment (Durcan et al, 2014). More recently, it has been found
that it can regulate basal autophagy in the absence of CCCP, although
its role has not been thoroughly characterized in this process and it is
controversial (Jacomin et al, 2015). USP8 is also highly expressed in
the brain and up-regulated in neurodegenerative conditions (Paiardi
et al, 2014), which makes it of neurological interest.
USP8 down-regulation correlates with decreased MFN protein
levels
We next validated if USP8 down-regulation correlated with changes
in MFN protein levels. Upon efﬁcient USP8 down-regulation in ﬂy
cells, as assessed by qPCR (Fig S1B), steady-state levels of en-
dogenous (Figs 1C and S1C) or exogenously expressed tagged MFN
were decreased (Fig 1D) and mitochondria appeared accordingly
fragmented (Fig S1D). The effect was speciﬁc for USP8 because re-
expression of USP8 in USP8 RNAi cells restored MFN levels (Fig 1D).
In contrast, in cells overexpressing USP8, levels of exogenously
expressed (Fig 1D) and endogenous MFNwere increased (Fig 1E) and
mitochondria were elongated and clumped, accumulating in the
perinuclear area (Fig S1E).
Wenext assessed the impact of USP8down-regulationonMFN levels
in vivo. To this aim, wedrove efﬁcient whole bodyUSP8 knockdown (KD)
by using the Actin5C driver (Act-GAL4>USP8-RNAi), achieving signiﬁcant
USP8 down-regulation at 29°C (Fig S1F). Attempts to increase USP8
down-regulation efﬁciency by using the stronger GAL4 driver daugh-
terless (da) caused larvae lethality, suggesting that USP8 expression
levels in vivo are tightly regulated. Act-GAL4>USP8-RNAi on the other
hand was viable with no apparent locomotor defects. As previously
observed in vitro, levels of MFN were reduced in vivo in USP8
down-regulating ﬂies (Fig 1F). We also found decreased MFN levels
in protein extracts coming from ﬂies carrying heterozygous USP8
gene deletion (USP8−/+) (Mukai et al, 2010), further supporting that
the effect is speciﬁc for USP8 (Fig 1G).
USP8 down-regulation ameliorates the phenotype of PINK1 KO
ﬂies
We addressed whether USP8 knockdown in PINK1 KO ﬂies pre-
vented the multiple phenotypes recapitulating key features of
locomotor and cellular defects manifested in the ﬂies as de-
generation of dopaminergic (DA) neurons and reduced climbing
ability. We also assessed the ﬂight muscle, mitochondria ultra-
structure, male fertility, and life span, all degenerated or affected in
PINK1 KO ﬂies (Clark et al, 2006; Park et al, 2006; Yang et al, 2006).
Immunostaining for the speciﬁc DA neuronal marker tyrosine hy-
droxylase (TH) allowed the inspection of the DA neuronal network
composed of well-characterized DA neuron clusters (PPM1, PPM2,
PPM3, PPL1, PPL2, and VUM) in brains (Fig 2A). PINK1 KO showed the
expected reduction in TH staining and exhibited a small but sig-
niﬁcant decrease in the number of DA neurons in the PPL1 DA
neuronal cluster (Fig 2B and C) (Park et al, 2006; Wang et al, 2006;
Yang et al, 2006). Accordingly, dopamine levels measured from
PINK1 KO heads were signiﬁcantly lower compared with control ﬂies
(Fig 2D). USP8 down-regulation completely prevented the loss of
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PINK1 KO DA neurons (Fig 2B and C), restoring dopamine to wild-
type levels (Fig 2D). Moreover, USP8 down-regulation ameliorated
the shorter longevity (Fig 2E), corrected thoracic muscle ﬁber
disorganization with enlarged electron transparent mitochondria
and irregular myoﬁbril arrays (Park et al, 2006) (Fig 2F) typical of the
PINK1 KO ﬂies (Park et al, 2006). More importantly, ultrastructural
transmission electron microscopy (TEM) analysis showed that the
mitochondrial cristae, fragmented and sparely packed in PINK1
mutants, were recovered with highly increased electron-dense
staining intensity (Fig 2G). USP8 knockdown also ameliorated the
PINK1 climbing defect (Fig 2H).
Table 1. Complete list of the 75 human known or predicted DUBs and their
ﬂy homologue, when known or predicted, based on sequence similarity.
Where available, Entrez/PubMed gene ID and ﬂy gene name is provided.
Gene name Gene ID Fly homologue Fly gene name
UCHL1 7345 CG4265
UCHL3 7347 CG4265
BAP1 8314 CG8445 CALYPSO
UCHL5/UCH37 51377 CG3431
DUB3 377630 CG5505 USP36/SCRAWNY
USP1 7398 CG15817 USP1
USP2 9099 CG14619
USP3 9960 CG5798 UBPY/USP8
USP4 7375 CG8334
USP5 8078 CG12082
USP6 9098 CG8334
USP7/HAUSP 7874 CG1490 USP7
USP8/USPY 9101 CG5798 UBPY/USP8
USP9X/FAM 8239 CG1945 FAT FACETS
USP10 9100 CG32479
USP11 8237 CG8334
USP12 219333 CG7023 USP12-46
USP13 8975 CG12082 USP5
USP14 9097 CG5384
USP15 9958 CG12082
USP16 10600 CG4165 USP16-45
USP18 11274 CG5486 USP64E/USP47
USP19 10869 CG8334
USP20 10868 CG8494
USP21 27005 CG14619
USP22 23326 N/A
USP24 23358 CG1945 FAT FACETS
USP25 29761 CG5794 PUF/USP34
USP26 83844 CG5798 USP8/USPY
USP27X 389856 CG4166 NOT
USP28 57646 CG5794 PUF/USP34
USP29 57663 CG5798 USP8/USPY
USP30 84749 CG3016
USP31 57478 CG30421 USP15-31
USP32 84669 CG8334
USP33 23032 CG8494 USP20-33
USP34 9736 CG5794 PUF/USP34
USP35 57558 CG8830 DUBAI
USP36 57602 CG5505
USP37 57695 CG5798 USP8/USPY
USP38 84640 CG8830 DUBAI
(Continued on following page)
Table 1. Continued
Gene name Gene ID Fly homologue Fly gene name
USP39 10713 CG7288
USP40 55230 CG5486 USP64E/USP47
USP41 373856 CG5486 USP64E/USP47
USP42 84132 CG5505 USP36/SCRAWNY
USP43 124739 CG30421 USP15-31
USP44 84101 CG5798 USP8/USPY
USP45 85015 CG4165 USP16-45
USP46 64854 CG7023 USP12-46
USP47 55031 CG5486 USP64E/USP47
USP48 84196 CG1490 USP7
USP49 25862 CG5798 USP8/USPY
USP50 373509 CG5798 USP8/USPY
USP51 158880 CG4166 NOT
USP52 9924 CG8232 PAN2
USP53 54532 CG2904 ECHINUS
USP54 159195 CG2904 ECHINUS
OTUB1 55611 CG4968
CYLD 1540 CG5603
TNFAIP3/A20 7128 CG9448 TRABID
OTUD1 220213 CG6091
YOD1 55432 CG4603
OTUD3 23252 CG6091
OTUD4 54726 CG12743 OTU
OTUD6A 139562 CG7857
OTUD6B 51633 CG7857
OTUD7A 161725 CG9448 TRABID
OTUD7B 56957 CG9448 TRABID
TRABID 54764 CG9448 TRABID
ATXN3 4287 CG13379
ATX3L N.A. CG13379
JOSD1 9929 CG3781
JOSD2 126119 CG3781
AMSH/STAMBP 10617 CG2224
AMSH-LP 57559 CG2224
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To independently validate the previous results, we analyzed a
bona ﬁde genetic mutant for USP8. Heterozygous USP8 gene de-
letion (USP8−/+) in PINK1 KO background also completely prevented
the loss of DA neurons (Fig 3A and B), restored dopamine levels to
wild-type (Fig 3C), corrected thoracic muscle ﬁber disorganization
(Fig 3D) and mitochondrial structure (Fig 3E), ameliorated the
shorter longevity (Fig 3F), and completely corrected the locomotor
defects (Fig 3G). Thus, these observations support the speciﬁcity of
the previous results and conﬁrm that loss of USP8 ameliorates
PINK1 KO phenotypes.
USP8 down-regulation rescues mitochondria defects of PINK1 KO
ﬂies
To verify if USP8 down-regulation also correlates to the amelio-
ration of mitochondrial function, impaired in PINK1 KO/KD models
Figure 1. A targeted siRNA screening identiﬁed DUB
USP8 whose down-regulation correlates with
decreased MFN levels.
(A) siRNA screen to identify DUBs affecting
pathologically elevated MFN protein levels. Protein
extracts from Drosophila S2R+ cells expressing equal
amounts of Flag-MFN and treated with 2 μg dsRNA probe
were separated by SDS–PAGE and immunoblotted using
an anti-Flag antibody. Densitometric analysis of MFN
signal normalized to loading control and expressed as
fold change (FC) versus control dsRNA was used as read
out to identify DUBs whose down-regulation affects MFN
protein levels. (B) Volcano plot constructed by plotting
the negative log of the FDR corrected P value (qval) on
the y-axis against the log of the FC calculated in (A).
Those points that are found toward the top of the plot
far to either the left- or right-hand side represent values
with large FC and high statistical signiﬁcance. A
threshold of P < 0.05 and 0.75 < FC > 1.3 led to the
identiﬁcation of four DUBs whose down-regulation
resulted in either decreased MFN levels (USP8 FC = 0.345 ±
0.04, qval = 0.024; USP14 FC = 0.537 ± 0.06, qval = 0.044) or
increased MFN levels (Echinus FC = 1.784 ± 0.13, qval =
0.024; USP36 FC = 1.524 ± 0.12, qval = 0.040). Down-
regulation of PINK1 or Parkin led to increasedMFN levels
(FC = 2.724 ± 0.44, qval = 0.045; and FC = 1.994 ± 0.28, qval =
0.045, respectively). (C) S2R+ cells were transfected with
the indicated siRNA (Ctrl and USP8) and lysed after 3 d.
Equal amounts of protein (30 μg) were separated by
SDS–PAGE and immunoblotted using the indicated
antibodies. Representative of n = 6. Graph bar shows
mean ± SEM of ratio between densitometric levels of
MFN and those of Actin from at least eight independent
experiments. Means are signiﬁcantly different according
to t test; P = 0.0025 (**), n = 6. (D) S2R+ cells were
transfected with the indicated plasmid (MFN-Flag, USP8)
and siRNA (Ctrl and USP8) and lysed after 3 d. Equal
amounts of protein (30 μg) were separated by SDS–PAGE
and immunoblotted using the indicated antibodies.
Representative of n = 5. Graph bar shows mean ± SEM of
ratio between densitometric levels of Flag (MFN) and
those of Actin relatively to control from at least four
independent experiments. One-way ANOVA; P < 0.0001
(****), followed by Tukey’s multiple comparison test. n =
5. (E) S2R+ cells were transfected with the indicated
plasmids (empty vector, ev or USP8) and lysed after 3 d.
Equal amounts of protein (30 μg) were separated by
SDS–PAGE and immunoblotted using the indicated
antibodies. Representative of n = 4. Graph bar shows
mean ± SEM of ratio between densitometric levels of
MFN and those of Actin relatively to control from at least
four independent experiments. Means are signiﬁcantly
different according to the t test; P = 0.0313 (*), n = 4. (F) Equal amounts of protein (70 μg), isolated fromwild-type (Ctrl) ﬂies or those down-regulating USP8 (USP8) separated
by SDS–PAGE and immunoblotted using the indicated antibodies. Representative of n = 8. Graph bar shows mean ± SEM of ratio between densitometric levels of MFN and
those of Actin relatively to control from at least three independent experiments. Means are signiﬁcantly different according to the t test; P = 0.0044 (**), n = 8. The ﬂies were
raised at 29°C to allow efﬁcient down-regulation of USP8. (G) Equal amounts of protein (70 μg), isolated fromwild-type (Ctrl) ﬂies and those carrying heterozygous deletion
of USP8 (USP8−/+) separated by SDS–PAGE and immunoblotted using the indicated antibodies. Representative of n = 5. Graph bar shows mean ± SEM of ratio between
densitometric levels of MFN and those of Actin relatively to control from at least four independent experiments. Means are signiﬁcantly different according to the t test; P =
0.0069 (**), n = 5.
Source data are available for this ﬁgure.
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(Clark et al, 2006; Gandhi et al, 2009; Morais et al, 2014; Park et al,
2006), we measured mitochondrial respiration in digitonin-
permeabilized cells, where mitochondria are directly accessible
to substrates. In line with what has been previously reported
(Gandhi et al, 2009; Morais et al, 2009), we found that ADP-
stimulated glutamate-supported respiration (state 3) was signiﬁ-
cantly reduced in cells lacking PINK1 (Fig S2A). State 3/basal (state
4) respiration ratio, also known as respiratory control ratio (RCR),
was reduced (Fig S2B). USP8 down-regulation did not perturb
mitochondrial respiration per se; however, it corrected the respi-
ration defects of the PINK1-deﬁcient cells (Fig S2A and B). In cells
lacking PINK1, mitochondrial dysfunction is mirrored also by
changes in mitochondrial membrane potential (Δψm) (Gandhi et al,
2009; Morais et al, 2009; Mortiboys et al, 2008). When we measured
latent mitochondrial dysfunction using a well-established assay
based on the response of Δψm to the ATPase inhibitor oligomycin,
as expected (Gandhi et al, 2009; Morais et al, 2009), we noticed that
PINK1-deﬁcient mitochondria sustain their Δψm by hydrolyzing
cytosolic ATP and therefore depolarize after oligomycin treatment
(Fig S2C–E). Although down-regulation of USP8 had no effect on
Δψm, in PINK1-deﬁcient cells, it fully prevented the oligomycin-
induced depolarization, further conﬁrming its beneﬁcial effects on
Figure 2. USP8 down-regulation corrects DA neuron loss, life span, muscle degeneration, and locomotor impairment of PINK1-deﬁcient ﬂies.
(A) Confocal images (projection, Z stack) of whole-mount adult brain (left panel) showing DA neuron clusters marked with an anti-TH antibody. Immunostaining
for the speciﬁc DA neuronal marker TH allows the inspection of the DA neuronal network composed by well-characterized DA neuron clusters (PPM1, PPM2, PPM3,
PPL1, PPL2, and VUM) in brains (right panel). (B) Whole brains of 15-d-old male ﬂies of the indicated genotypes were immunostained with anti-TH antibody. Panel shows
confocal images of PPL1 cluster DA neurons of the indicated genotypes. Representative of n = 15. (C) Bar graph shows the number of DA neurons in the PPL1
cluster of the brains of the indicated genotypes. One-way ANOVA, P < 0.0001 (****) followed by Tukey’s multiple comparison test; n = 15. (D) Relative dopamine amount from
15-d-old adult heads of the indicated genotype normalized to control ﬂies. One-way ANOVA, P = 0.0073 (**) followed by Tukey’s multiple comparison test. n = 4. (E)
Life span analysis of adult males of the indicated genotypes. Male ﬂies of the indicated genotypes were collected during 12 h after hatching and transferred to
fresh food every 2 d and dead ﬂies were counted in the same interval. At least 100 ﬂies per genotype were used for the analysis. Log-rank, Mantel–Cox test (Ctrl versus PINK1
KO P < 0.0001; Ctrl versus PINK1 KO USP8 RNAi P < 0.0001; Ctrl versus USP8 RNAi P > 0.05; PINK1 KO versus PINK1 KO USP8 RNAi P < 0.0001; PINK1 KO versus USP8 RNAi P <
0.0001; and PINK1 KO USP8 RNAi versus USP8 RNAi P < 0.0001 P < 0.0001). (F) Ultrastructural analysis of the indirect ﬂight muscles from ﬂy thoraces of the indicated
genotypes. Images show TEM images of thorax muscles from ﬂies of the indicated genotypes. Representative of n = 3. (G) Enlarged TEM images of ﬂight muscle
mitochondria of the indicated genotypes. Representative of n = 3. (H) Graph bar shows mean ± SEM of the climbing performance of ﬂies of the indicated genotype from at
least three independent experiments. One-way ANOVA, P < 0.0001 (****); Tukey’s multiple comparison test; n = 3.
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mitochondrial function (Fig S2C–E). Because USP8 participates in a
multiplicity of pathways (Alexopoulou et al, 2016; Durcan & Fon,
2015; Mizuno et al, 2005; Row et al, 2006), the beneﬁcial effects on
mitochondrial function measured in situ might be indirect. We,
therefore, compared the function of mitochondria puriﬁed from
PINK1-mutant (KO) ﬂies with that recorded inmitochondria isolated
from PINK1 KO ﬂies where we down-regulated USP8 (Fig 4A and B) or
from double heterozygous USP8-deﬁcient (USP8−/+), PINK1 KO ﬂies
(Fig 4C and D). As expected, glutamate-supported ADP-stimulated
respiration was reduced, resulting in lower RCR in isolated PINK1 KO
mitochondria (Gandhi et al, 2009; Morais et al, 2009) (Fig 4A–D). On
the other hand, USP8 RNAi (Fig 4A and B) or heterozygous USP8
gene deletion (Fig 4C and D) in PINK1 KO ﬂies normalized ADP-
stimulated respiration and RCR.
Blue Native PAGE (BN-PAGE) of mitochondrial extracts lent
further biochemical support to the measured functional amelio-
ration. Extracts from PINK1-deﬁcient ﬂies displayed reduced levels
of respiratory complex I, which was corrected by heterozygous
deletion of USP8 (Fig 4E and F). PINK1 mutants show reduced
enzymatic activity of complex I (Morais et al, 2014; Pogson et al,
2014). Both USP8 ﬂy lines (USP8+/− and USP8 RNAi) restored
complex I activity of PINK1 mutants (Fig 4G and H).
Figure 3. Heterozygous USP8 gene deletion corrects
DA neuron loss, life span, muscle degeneration, and
locomotor impairment of PINK1-deﬁcient ﬂies.
(A) Whole brains of 15-d-old male ﬂies of the indicated
genotypes were immunostained with anti-TH antibody.
Panel shows confocal images of DA neuron of the PPL1
cluster of the indicated genotypes. Representative of
n = 11. (B) Bar graph shows the number of DA neurons in
the PPL1 cluster of the brains of the indicated
genotypes. One-way ANOVA, P < 0.0001 (****); Tukey’s
multiple comparison test; n = 11. (C) Relative dopamine
amount from 15-d-old adult heads of the indicated
genotype normalized to control ﬂies. One-way ANOVA,
P = 0.0002 (***); Tukey’s multiple comparison test; n = 5.
(D) TEM images of thorax muscles from ﬂies of the
indicated genotypes. Representative of n = 3. (E)
Enlarged TEM image of ﬂight muscle mitochondria of
the indicated genotypes. Representative of n = 3. (F) Life
span analysis of adult males of the indicated
genotypes. Male ﬂies of the indicated genotypes were
collected during 12 h after hatching and transferred to
fresh food every 2 d and dead ﬂies were counted in the
same interval. At least 100 ﬂies per genotype were used
for the analysis. Log-rank, Mantel–Cox test (Ctrl versus
PINK1 KO P < 0.0001; Ctrl versus PINK1 KO USP8−/+ P <
0.0001; Ctrl versus USP8−/+ P > 0.05; PINK1 KO versus
PINK1 KO USP8−/+ P < 0.0001; PINK1 KO versus USP8−/+
P < 0.0001; and PINK1 KO USP8−/+ versus USP8−/+ P <
0.0001 P < 0.0001). (G) Graph bar shows mean ± SEM of
the climbing performance of ﬂies of the indicated
genotype from at least three independent experiments.
One-way ANOVA, P < 0.0001 (****); Tukey’s multiple
comparison test; n = 3.
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PINK1-null mutant males are sterile, as a consequence of
spermatogenesis defects deriving from mitochondrial dysfunction
(Clark et al, 2006; Deng et al, 2008; Greene et al, 2003; Park et al,
2006). Of note, heterozygous USP8 gene deletion favours the re-
storing of sperm production of the PINK1 KO, rescuing male sterility
(Fig S3). The seminal vesicles of Ctrl and USP8−/+ males were well
developed, swollen, and brownish in color (Fig S3A and B), whereas
those of PINK1 KO were reduced in volume and more transparent
(Fig S3C). Puncturing the vesicles of Ctrl and USP8−/+ males released
a large amount of sperm (Fig S3E and F), whereas sperm was almost
absent in PINK1 KO vesicles (Fig S3G). Rescued males (PINK1 KO,
USP8−/+) showed an intermediate pattern, with swollen, opaque
vesicles (Fig S3D) releasing some sperm groups (Fig S3H). The
ﬂuorescence staining revealed a difference among the four male
groups also in the accessory glands’ wall, whose cells appeared
alive (green) in ctrl and USP8−/+ males (Fig S3I and J) and dead (red)
in PINK1 KO (Fig S3K). In rescued males (PINK1 KO, USP8−/+), part of
the accessory glands’ cells was alive (Fig S3L). The result of
Figure 4. USP8 down-regulation rescues PINK1-deﬁcient
mitochondria respiratory defects ex vivo.
(A) Representative traces of oxygen consumption of intact
isolated mitochondria extracted from ﬂies of the indicated
genotype and subjected to 10 mM/5 mM pyruvate/malate
200 μM ADP, 2 μg/ml oligomycin, and 200 nM FCCP, 2 μM
antimycinA, respectively. Representative of n = 5. (B)
Quantitative analysis of respiratory ﬁtness of isolated
mitochondria extracted from ﬂies of the indicated genotype
treated as in (A). Graph showsmean ± SEM (n = 5 independent
experiments) of RCR relative to ctrl. One-way ANOVA, P =
0.0074 (**); Tukey’s multiple comparison test; n = 5. (C)
Representative traces of oxygen consumption of intact
isolated mitochondria extracted from ﬂies of the indicated
genotype and subjected to 10 mM/5 mM pyruvate/malate
200 μM ADP, 2 μg/ml oligomycin, and 200 nM FCCP, 2 μM
antimycinA, respectively. Representative of n = 5. (D)
Quantitative analysis of respiratory ﬁtness of isolated
mitochondria extracted from ﬂies of the indicated genotype
treated as in (G). Graph shows mean ± SEM (n = 5
independent experiments) of RCR relative to ctrl. One-way
ANOVA, P = 0.0064 (**); Tukey’s multiple comparison test; n =
5. (E) Blue Native PAGE of mitochondrial extracts from ﬂies of
the indicated genotypes. Respiratory complexes were
separated in a non-denaturing polyacrylamide gel.
Representative of n = 3. (F) Densitometric analysis of (E).
Graph bar shows mean ± SEM of ratio between densitometric
levels of complex I (CI) and those of complex V (CV). One-way
ANOVA, P = 0.0282 (**); Tukey’s multiple comparison test; n =
3. (G) Graph shows mean ± SEM (n = 4 independent
experiments) of complex I activity relatively to citrate
synthase (CS) activity in isolated 2.5 μM alamethicin-treated
mitochondria extracted from ﬂies of the indicated genotype.
One-way ANOVA, P = 0.0012 (**); Tukey’s multiple comparison
test; n = 4. (H) Graph shows mean ± SEM (n = 7 independent
experiments) of complex I activity relatively to CS activity in
isolated 2.5 μM alamethicin-treated mitochondria extracted
from ﬂies of the indicated genotype. One-way ANOVA, P <
0.0001 (****); Tukey’s multiple comparison test; n = 7.
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ﬂuorescence staining proves that the effect is not limited to sperm
production, but it is also extended to the functionality of the ac-
cessory glands, that play a crucial role on both male fertilization
success and female fertility (Simmons & Fitzpatrick, 2012).
Taken together, these analyses show that the mitochondrial-
defective phenotype of PINK1 KO ﬂies can be recovered by de-
creasing USP8 expression, including complex I levels and activity.
Pharmacological inhibition of USP8 corrects PINK1-deﬁcient ﬂies
The genetic experiments showed that USP8 inhibition amelio-
rates all the phenotypes that we tested that are associated to
Drosophila PINK1 KO. We, therefore, decided to test in vivo the
effect of DUBs-IN-2 (ChemScene LLC), a potent and membrane-
permeant USP8 drug inhibitor. DUBs-IN-2 is highly selective for
USP8 with a half maximal inhibitory concentration (IC50) of 0.28
μM (Colombo et al, 2010) and small or no effect on USP7 (IC50 >
100 μM for USP7). The compound has been described as an
inhibitor of human USP8, which shares about ~45% sequence
homology to the ﬂy ortholog. DUBs-IN-2 was mixed in the ﬂy food
with the food-coloring patent blue V (E131) to monitor drug
ingestion (Fig S4A). Increasing inhibitor concentrations did not
affect the food uptake of ﬂies as measured by E131 absorbance in
ﬂy lysates (Fig S4B) and did not affect locomotor behavior in a
control background (Fig S4C). Remarkably, DUBs-IN-2 adminis-
tered to adult PINK1-deﬁcient ﬂies signiﬁcantly suppressed the
locomotor deﬁcits (Fig 5A). Dose–response curve indicated the
best rescue of PINK1 KO climbing performance upon 10 μM DUBs-
IN-2 administration (Fig S4C). DUBs-IN-2 administration to PINK1
KO ﬂies also prevented loss of DA neurons (Fig 5B and C), re-
stored dopamine levels (Fig 5D), and it modestly ameliorated
longevity (Fig 5E).
USP8 down-regulation corrects pathologically elevated MFN
levels of PINK1 and Parkin KO ﬂies
PINK1 loss-of-function results in increased MFN protein levels
(Tanaka et al, 2010; Ziviani et al, 2010), altered mitochondrial
morphology (Mortiboys et al, 2008; Narendra et al, 2008; Tanaka et
al, 2010; Ziviani et al, 2010), impaired mitophagy (Gegg et al, 2010;
Figure 5. Pharmacological USP8 inhibition corrects DA
neuron loss, life span, muscle degeneration, and
locomotor impairment of PINK1-deﬁcient ﬂies.
(A) Graph bar shows mean ± SEM of the climbing
performance of 3-d-old ﬂies of the indicated genotype or
treated with DUBs-IN-2 or DMSO for 48 h from at least
four independent experiments. Two-way ANOVA P <
0.0001 (****); Tukey’s multiple comparison test; n = 8. (B)
Whole brains of 15-d-old male ﬂies of the indicated
genotypes or treated with DUBs-IN-2 for 15 d were
immunostained with anti-TH antibody. Panel shows
(projection, Z stack) confocal images of PPL1 cluster DA
neurons of the indicated genotypes. Representative of n
= 9. (C) Bar graph shows the number of PPL1 cluster DA
neurons in brains of the indicated genotypes treated
with DUBs-IN-2 or DMSO for 15 d. Two-way ANOVA, P =
0.0004 (***); Tukey’s multiple comparison test; n = 15. (D)
Relative dopamine amount from 15 d old adult heads of
the indicated genotype treated with DUBs-IN-2 or DMSO
for 15 d normalized to control ﬂies. Two-way ANOVA P =
0.0217 (*); Tukey’s multiple comparison test; n = 3. (E) Life
span analysis of male ﬂies of the indicated genotypes
treated with DUBs-IN-2 or DMSO. At least 100 ﬂies were
used for the analysis. Log-rank, Mantel–Cox test (Ctrl
versus PINK1 KO P < 0.0001; Ctrl versus PINK1 KO+DUBs-
IN-2, P < 0.0001; Ctrl versus Ctrl+DUBs-IN-2 P > 0.05; PINK1
KO versus PINK1 KO+DUBs-IN-2 P < 0.001; PINK1 KO versus
Ctrl+DUBs-IN-2 P < 0.0001; and PINK1 KO+DUBs-IN-2
versus Ctrl+DUBs-IN-2 P < 0.0001).
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Narendra et al, 2008; Ziviani et al, 2010), and oxidative phosphor-
ylation (Morais et al, 2009, 2014), with mitochondrial Ca2+ overload
and increased reactive oxygen species production (Gandhi et al,
2009). Similar phenotypes are caused by altered MFN, which
prompted us to investigate whether USP8 down-regulation cor-
rected pathologically elevated MFN levels of PINK1 KO ﬂies. Indeed,
USP8 down-regulation in vivo completely normalized increased
MFN levels of PINK1 KO (Fig 6A). Pharmacological inhibition of USP8
also led to reduced PINK1 KO MFN protein levels in ﬂies, indicating
that the inhibitor phenocopied genetic inhibition of USP8 (Fig 6B).
Like PINK1, Parkin KO/KD also results in increased MFN protein
levels (Gegg et al, 2010; Tanaka et al, 2010; Ziviani et al, 2010). We,
therefore, assessed the effect of USP8 KD in a Parkin loss-of-
function model of pathologically elevated MFN levels. USP8 KD
corrected elevated MFN levels of Parkin KO ﬂies (Fig 6C). It also
recovered the disorganized muscle ﬁbers with irregular arrange-
ment of myoﬁbrils and the swollen mitochondria of Parkin ﬂies
(Fig 6D), and normalized the number of DA neurons that are de-
creased in Parkin KO background (Fig 6E). Interestingly, USP8 KD or
inhibition did not correct climbing defects in Parkin KO ﬂies (Fig 6F),
nor in PINK1:Parkin double KO (Fig 6G).
Discussion
Interventions that decrease MFN levels in PINK1 or Parkin KO ﬂies
can ameliorate the multiple phenotypes that are associated with
the KO backgrounds (Deng et al, 2008; Poole et al, 2008; Liu et al,
2011; Vilain et al, 2012; Celardo et al, 2016). We, therefore, conducted
an RNAi-based screening to identify DUBs that regulate MFN protein
levels. We found USP8, a DUB previously identiﬁed in the regulation
of endosomal trafﬁcking (Mizuno et al, 2005; Row et al, 2006), CCCP-
induced mitophagy (Durcan et al, 2014) and basal autophagy
(Jacomin et al, 2015), and which down-regulation is protective from
Figure 6. USP8 down-regulation corrects pathologically elevated MFN levels of PINK1 and Parkin KO ﬂies.
(A) Equal amounts of protein (70 μg), isolated from ﬂies of the indicated phenotype were separated by SDS–PAGE and immunoblotted using the indicated antibodies.
Representative of n = 6. Graph bar shows mean ± SEM of ratio between densitometric levels of MFN and those of Actin from at least six independent experiments. One-way
ANOVA, P = 0.0003 (***); Tukey’s multiple comparison test; n = 6. (B) Equal amounts of protein (70 μg), isolated from ﬂies treated with DUBs-IN-2 or DMSO for 48 h were
separated by SDS–PAGE and immunoblotted using the indicated antibodies. Representative of n = 3. Graph bar shows mean ± SEM of ratio between densitometric levels of
MFN and those of Actin from at least three independent experiments. Two-way ANOVA, P < 0.00001 (****); Tukey’s multiple comparison test; n = 3. (C) Equal amounts of
protein (70 μg), isolated from ﬂies of the indicated phenotype were separated by SDS–PAGE and immunoblotted using the indicated antibodies. Representative of n = 9.
Graph bar shows mean ± SEM of ratio between densitometric levels of MFN and those of Actin from at least nine independent experiments. One-way ANOVA, P < 0.0001
(****); Tukey’smultiple comparison test; n = 9. (D) TEM images of thoraxmuscles from ﬂies of the indicated genotypes. Thoraces were dissected from 3-d-old adult ﬂies and
ﬁxed in 2% paraformaldehyde and 2.5% gluteraldehyde. The samples were rinsed, dehydrated, and embedded using Epon. Ultrathin sections were examined using TEM.
Representative of n = 3. (E) Bar graph shows the number of DA neurons in the PPL1 cluster of the brains of the indicated genotypes. One-way ANOVA, P < 0.0001 (****);
Tukey’s multiple comparison test; n = 10. (F) Graph bar shows mean ± SEM of the climbing performance of ﬂies of the indicated genotype from at least three independent
experiments. One-way ANOVA, P < 0.0001 (****); n = 3. (G) Graph bar shows mean ± SEM of the climbing performance of ﬂies of the indicated genotype from at least three
independent experiments. Two-way ANOVA, P < 0.0001 (****); Tukey’s multiple comparison test; n = 7.
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α-synuclein–induced locomotor deﬁcits in ﬂies (Alexopoulou et al,
2016). Our data show that inhibition of USP8 in vitro and in vivo
correlated with decreased mitochondrial fusion protein MFN, one
of the bona ﬁde Parkin targets (Gegg et al, 2010; Poole et al, 2010;
Tanaka et al, 2010; Ziviani et al, 2010; Sarraf et al, 2013) (Fig 1),
ameliorated PINK1 KO phenotypes in vivo (Figs 2, 3, and 5) and PINK1
KO mitochondrial dysfunction (Fig 4), and corrected MFN protein
levels, increased in PINK1 KO models (Fig 6). Interestingly, USP8 KD
also corrected MFN protein levels of Parkin KO ﬂies, indicating that
the effect on the levels of MFN is Parkin independent. USP8 KD also
prevented Parkin KO DA neurons loss and normalized mitochon-
drial morphological defects, although it did not ameliorate Parkin
climbing performance (Fig 6).
It has been shown that the knockdown of MFN is able to rescue
the mitochondrial defects and the overall phenotypes of Dro-
sophila PINK1 KO ﬂies (Deng et al, 2008; Poole et al, 2008). More
recently, it was shown that MFN knockdown can suppress loss of DA
neurons of the PPL1 cluster and thorax deformation resulting from
crushed thoracic muscle of the PINK1 KO ﬂies, but not the mito-
chondrial defects (Celardo et al, 2016). We found that normalizing
MFN levels of PINK1 KO ﬂies by driving efﬁcient whole body MFN KD
(Debattisti et al, 2014) ameliorated the disorganized muscle ﬁbers
and mitochondria ultrastructure of PINK1 KO ﬂies, but dopamine
content and climbing performance were only modestly recovered,
even if MFN levels of PINK1 KO ﬂies were completely corrected (Fig
S5). This result indicates that MFN normalization deriving fromUSP8
KD likely contributes to the amelioration of the PINK1 phenotype
but does not explain the full recovery of the multiple phenotypes
that are associated with PINK1 loss. Indeed, our in vivo analysis
indicates that USP8 KD has a broader protective effect than MFN KD
and unlike MFN KD (Celardo et al, 2016; Vilain et al, 2012), it cor-
relates with full correction of mitochondrial respiratory defects,
complex I content and activity, and mitochondrial membrane
potential of PINK1 KO ﬂies (Figs 4 and S2). Previous examination of
the PINK1-mutant phenotype demonstrated that although de-
creasing mitochondrial fusion rescues morphological mitochon-
drial defects of PINK1 ﬂies, manipulation of mitochondrial fusion (or
ﬁssion) does not rescue other PINK1-related phenotypes such as
the reduced activity of complex I, loss of mitochondrial membrane
potential, ATP content, and defective neurotransmitter release
(Vilain et al, 2012; Vos et al, 2012). In light of this, we hypothesize that
the protective effect of USP8 inhibition comes from a combination
of signaling pathways, which directly or indirectly impinges on MFN
levels and mitochondrial function. In mammals, it is established
that USP8 is involved in endosomal trafﬁcking (Clague et al, 2013),
although its activity can have opposing effects. For instance,
deubiquitination by USP8 was reported to slow the degradation of
substrates (Mizuno et al, 2005; Mukai et al, 2010), but also to fa-
cilitate endosomal trafﬁcking and lysosomal degradation (Row et
al, 2007; Ali et al, 2013). shRNA against USP8 in SH-SY5Y neuro-
blastoma cells promotes α-synuclein degradation by the lysosome,
which exerts a protective effect in vivo in an α-synuclein ﬂy model
of PD (Alexopoulou et al, 2016). It was also reported that USP8 is
required for lysosomal biogenesis and productive autophagy in
Drosophila larval fat body but inhibits basal autophagy in vitro in
HeLa cells (Jacomin et al, 2015). Finally, deubiquitination of Parkin
by USP8 is required for Parkin recruitment to CCCP-intoxicated
mitochondria and to promote stress-induced mitophagy in vitro
(Durcan et al, 2014). Thus, USP8 down-regulation in this context inhibits
Parkin recruitment to mitochondria, causing a delay in mitochondria
clearance by mitophagy. In light of these seemingly opposing phe-
notypic outcomes, it is clear that USP8 has pleiotropic effects that
depends on the speciﬁc genetic repertoire of the cell/tissue, varies in
response to physiological versus pathological conditions, or might
simply operate differently in cell lines versus the whole organism.
Our model is consistent with a role of USP8 in controlling mi-
tochondrial function via Parkin-independent regulation of
pathologically elevated MFN protein levels. Yet, it does not ex-
clude MFN-unrelated pathways that nevertheless impinge on
mitochondrial function via Parkin, like the mitochondrial-derived
vesicle pathway regulating mitochondria quality control
(McLelland et al, 2014), or the endosomal–lysosomal pathway that
can also play a role in selective degradation of dysfunctional
mitochondria (Hammerling et al, 2017a, 2017b). Interestingly, it was
shown in the latter that the autophagic activity is increased when
the endosomal activity is impaired, sustaining the hypothesis that
there is crosstalk between the various degradation pathways to
ensure effective clearance. It is tempting to hypothesis an en-
hancement of autophagy deriving from USP8 KD to complement
for impaired endosomal-mediated quality control. For these
reasons, future studies need to be conducted in vivo to validate
this hypothesis and clearly dissect coordination and timing of
activation of these pathways in different tissues under physio-
logical and pathological conditions.
Because of their involvement in the regulation of important
signaling pathways, DUBs are emerging as extremely attractive
druggable candidates (Sugiura et al, 2013). In recent years, many
DUBs emerged as therapeutic targets to compensate for impaired
mitophagy in PD (Bingol et al, 2014; Cornelissen et al, 2014; Wang et
al, 2015; Chakraborty et al, 2018). Mitophagy is triggered by ubiquitin
modiﬁcation of mitochondrial proteins, which is in principle
subject to suppression by deubiquitination. It is, therefore, rea-
sonable that inhibition of speciﬁc DUBs should induce mitophagy
and that it does so by deubiquitination mitochondrial proteins.
Clinical trials for speciﬁc inhibitors of the ubiquitin–proteosome
system have already been approved in cancer therapy for the
treatment of multiple myeloma (Colland, 2010). Moreover, high-
throughput screening of small chemical libraries identiﬁed non-
selective DUB inhibitors as potent inducers of apoptosis in various
cancer cells (Liu et al, 2003; Brancolini, 2008; Engels et al, 2009;
Hussain et al, 2009; Py et al, 2013). Similarly, speciﬁc DUB inhibitors
(or activators) can affect cellular response to stimuli that induce
cell death. In this respect, the identiﬁcation of a speciﬁc DUB that
normalizes mitochondrial function might be instrumental to de-
velop speciﬁc isopeptidase inhibitors that can modulate the
fundamental biological process of mitochondria physiology and
ﬁtness, supporting the potential of USP8 inhibitors as therapeutics.
Online methods
Cell culture and transfection
Drosophila S2R+ cells were cultured in Schneider’s medium
(Invitrogen) supplemented with 10% heat-inactivated fetal calf
serum (Sigma-Aldrich). The cells were maintained at 25°C and
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passaged routinely before they reached conﬂuence, to maintain a
logarithmic growth. The cells were transfected using TransFectin
lipid reagent (Bio-Rad) or Effectene (QIAGEN) following the man-
ufacturer’s instructions. In brief, 0.6 million cells were plated in six-
well plate and transfected with 2 μg DNA/5 μl TransFectin or 1 μg
DNA/10 μl Effectene + 8 μl Enhancer, 1 d after plating. The cells were
collected 24–48 h after transfection. 500 μM copper sulfate solution
was added to the cells to induce plasmid expression when
required.
Plasmids
MitoDsRed was subcloned from pDsRed2-Mito vector (Clontech)
into pAct-PPA expression plasmid. C-terminal Flag tag MFN was
obtained by ampliﬁcation from cDNA clone (RE04414) and subcl-
oned into pAct-PPA expression plasmid. CG5798/USP8 was am-
pliﬁed from cDNA clone and subcloned into pMt copper-inducible
vector (Invitrogen).
Gene silencing
Drosophila dsRNA probes were prepared using MEGA script kit
(Ambion) following the manufacturer’s instructions. The fol-
lowing primers have been used to prepare the RNAi probes:
PINK1 CAATGTGACTTCTCCAGCGA and TCGTAGCGTTTCATCAGCAG;
Parkin CTGTTGCAATTTGGAGGGA and CTTTGGCACGGACTCTTTCT;
and MFN GGAACCTCTTTATTCTCTAT and GGTTTGCTTTGCCCCAA-
CAT. CG5798/USP8 dsRNA probe was acquired from the Shefﬁeld
RNAi Screening Facility. 1.2 millions cells were plated on a six-well
plate and treated with 7 μg RNAi probe in serum-free medium. 2 h
after the probe treatment, complete medium was added to the
wells, and the cells were cultured for 2 d before being transfected
with indicated ﬂy expression plasmids as previously described.
Immunoblotting
Western blotting was performed using standard techniques. In
brief, the cells were collected in lysis buffer (50 mM Tris–HCl, pH 8,
150 mM HCl, 1 mM MgCl2, 2 mM EGTA, 1% Triton X, 10% glycerol, 10
mM NEM, 10 μM MG132 and protease inhibitor cocktail by Roche)
and incubated on ice for 30 min before being centrifuged at
maximum speed at 4°C. Ten to twelve ﬂies were homogenized
using a mortar and pestle in protein extraction buffer (200–300 μl,
150 mM NaCl, 5 mM EDTA, pH 8.0, 50 mM Tris, pH 8.0, 1% NP-40, 0.1%
SDS 0.1, supplemented with 10 μM MG132, 10 mM NEM, and pro-
tease inhibitor cocktail). The following commercial antibodies
were used: anti-Flag (1:1,000; Cell Signaling Technology), anti-
Actin (1:10,000; Chemicon) has been described before. Anti-
Drosophila Mitofusin (1:2000) was raised in rabbit against an
N-terminal peptide, DTVDKSGPGSPLSRF. For detection, secondary
antibodies conjugated with HRP (Chemicon) were used (1:3,000),
and immunoreactivity was visualized with ECL chemiluminescence
(Amersham).
Live imaging
Cells were grown on imaging dishes (Chamber Slide Lab-Tek II 8;
Thermo Fisher Scientiﬁc) or coverslips. After appropriate treatment,
when indicated, the cells were treated with the selective mito-
chondrial dye Mitotracker (50 nM; Molecular Probe) for 10 min,
washed three times with PBS, and imaged live in growing medium
under ambient conditions on an Andromeda iMIC spinning disk live
cell microscope with confocal resolution (TILL Photonics, 60X ob-
jective). For confocal z-axis stacks, 40 images separated by 0.2 μm
along the z-axis were acquired.
For measurements of mitochondrial membrane potential, the
cells were loaded with 25 nM tetramethylrhodamine methyl ester
(TMRM) for 30 min at room temperature, and the dye was present
during the experiment together with the multidrug resistance in-
hibitor cyclosporine H (1 μM). The cells were then observed using an
Olympus IX81 inverted microscope equipped with a cell imaging
system. Sequential images of TMRM ﬂuorescence were acquired
every 60 s with a 40× objective (Olympus). Where indicated,
oligomycin (2.5 μg/ml; Sigma-Aldrich) or the uncoupler carbonyl
cyanide p-triﬂuoromethoxyphenylhydrazone (CCCP, 10 μM; Sigma-
Aldrich) was added. TMRM ﬂuorescence analysis over the mito-
chondrial regions of interest was performed using ImageJ. A
reduction in TMRM ﬂuorescence represents mitochondrial mem-
brane depolarization. In the graph bars, we indicated TMRM ﬂuo-
rescence after 30-min oligomycin administration in the cells of the
indicated genotypes. The cells were always loaded in the presence
of the multidrug resistance inhibitor cyclosporine H.
Mitochondria morphology analysis
Quantiﬁcation of mitochondria length was performed by using
ImageJ software. To measure mitochondrial length, we created
maximum-intensity projections of z-series with 0.2-μm increments.
Quantiﬁcation was then performed by using “Squassh” (Segmen-
tation and QUAntiﬁcation of Subcellular SHapes), a plugin com-
patible with the image processing software ImageJ or Fiji, freely
available from http://mosaic.mpi-cbg.de/?q=downloads/imageJ.
Squassh is a segmentation method that enables both colocaliza-
tion and shape analyses of subcellular structures in ﬂuorescence
microscopy images (Rizk et al, 2014). For our analysis, segmentation
was performed with the minimum intensity threshold set to 0.15
and the regularization weight to 0.015.
The mitochondria morphology score was assigned as in Pogson
et al (2014). Brieﬂy, a morpho score is assigned to each imaged cell
according to the morphology of its mitochondrial network. Num-
bers represent the designated “morphology score”: 0 = cell with a
full complement of mitochondria; 1 = cell with a full complement of
mitochondria and some clumped mitochondria; 2 = cell with a
reduced mitochondrial network and some clumped mitochondria;
3 = cell with a clumped mitochondrial network; and 4 = cell with a
complete clumped mitochondrial network.
Total RNA extraction and qRT-PCR
Total RNA was extracted from Drosophila S2R+ cells using TRI
Reagent (Sigma-Aldrich) according to the manufacturer’s in-
structions. The RNA pellet was dissolved in 5–10 μl RNAase-free
water. Total RNA was extracted from approximately 10 ﬂies using
Trizol (Life Technologies) and further puriﬁed by precipitation with
LiCl 8M. RNA samples were checked for integrity by capillary
electrophoresis (RNA 6000Nano LabChip; Agilent Technologies). For
each sample, 1 μg of RNA was used for ﬁrst-strand cDNA synthesis,
using 10 μM deoxynucleotides, 10 μM oligo-dT, and SuperScript II
(Life Technologies). qRT-PCRs were performed in triplicate in a 7500
Real-Time PCR System (Life Technologies) using SYBR Green
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chemistry (Promega). The 2−ΔΔCt (RQ, relative quantiﬁcation) method
implemented in the 7500 Real-Time PCR System software was used to
calculate the relative expression ratio (ref.). The USP8 oligonucleo-
tides primer used were USP8_F (CACCCATTCAAATTGTCGAG) and
USP8_R (TCGATGGTCTCAATGTCGTT). Rp49 was used as endogenous
control and the oligonucleotides used were Rp49 F (ATCGGTTACG-
GATCGAACAA) and R (GACAATCTCCTTGCGCTTCT).
Drosophila stocks and procedures
Drosophila were raised under standard conditions at 25°C unless
differently stated on agar, cornmeal, yeast food. park25 mutants
and UAS-Parkin have been described before (Greene et al, 2003).
PINK1B9 mutants (Park et al, 2006) were provided by Dr. J Chung
(KAIST). w1118 and Act-GAL4 strains were obtained from the
Bloomington Drosophila Stock Center. UAS-USP8 RNAi and UAS-
Marf RNAi lines were obtained from the VDRC Stock Center.
Usp8−/+ and UAS-Usp8 (uspy) lines were kindly provided by S
Goto (Mukai et al, 2010).
Climbing assays
Climbing assays were performed as previously described (Greene et
al, 2003). For the climbing assay upon drug treatment, groups of 10
ﬂies were collected and placed into an empty vial (12 × 5 cm) with a
line drawn at 6 cm from the bottom of the tube. The ﬂies were gently
tapped to the bottom of the tube, and the number of ﬂies that
successfully climbed above the 6-cm mark after 10 s was noted.
Fifteen separate and consecutive trials were performed for each
experiment, and the results were averaged. At least 40 ﬂies were
tested for each genotype or condition. Data collection and analysis
were performed blind to the conditions of the experiments unless
otherwise indicated.
Isolation of mitochondria
Mitochondria were extracted from whole ﬂies by differential cen-
trifugation. Each sample was homogenized using a Dounce
glass–glass potter and a loose-ﬁtting pestle in a mannitol–sucrose
buffer (225 mM mannitol, 75 mM sucrose, 5 mM Hepes, and 0.1 mM
EGTA, pH 7.4) supplemented with 2% BSA. The samples were then
centrifuged at 1,500 g at 4°C for 6 min. The pellet was discarded by
ﬁltering the sample through a ﬁne mesh, and the supernatant was
centrifuged at 7,000 g at 4°C for 6 min. The resulting pellet was
resuspended in mannitol–sucrose buffer without BSA before being
centrifuged at 7,000 g under the same conditions as above and
resuspended in a small volume of mannitol–sucrose buffer. Protein
concentration was measured using the biuret test.
Mitochondrial respiration
Rates of mitochondrial respiration were measured using the
Oxytherm System (Hansatech) with magnetic stirring and ther-
mostatic control maintained at 25°C. Isolated Drosophila mito-
chondria (1 mg/ml) were incubated in 120 mM KCl, 5 mM Pi-Tris,
3 mM Hepes, 1 mM EGTA, and 1 mMMgCl2, pH 7.2, and additions were
made as indicated in the ﬁgure legends. O2 consumption was
calculated according to the slope of the registered graph and
plotted as ng atoms: O2 × min−1 × mg−1. RCR (ADP-stimulated res-
piration over basal respiration) was calculated.
Immunostaining of whole-mounted brains
Brains of 15-d-old male control or mutant ﬂies were dissected in
ice-cold PBS and ﬁxed in 4% PFA at room temperature for 20 min.
Samples were washed six times for 10 min with PBS + 0.3% Triton
X-100, permeabilized with PBS + 1% Triton X-100 for 10 min, and
blocked with PBS + 0.3% Triton X-100 containing 1% BSA overnight at
4°C. For immunostaining of DA neurons, rabbit anti-TH antibody
(Millipore) diluted 1:100 in PBS + 0.3% Triton X-100 containing 0.3%
BSA was added and incubated over three nights at 4°C. Brains were
washed and blocked again as described above, despite the blocking
this time being carried out at RT for 1 h. The immunoreaction was
revealed with Cy3-conjugated anti-rabbit IgG (Jackson Immuno-
Research) at a working dilution of 1:500 in PBS + 0.3% Triton X-100
containing 0.3% BSA overnight at 4°C. After another six washing
steps, whole brains were mounted with Vectashield (Vector Lab-
oratories). Z-stack images were obtained by a Zeiss LSM700 con-
focal microscope.
Drug treatment
The speciﬁc USP8 inhibitor DUBs-IN-2 (ChemScene LLC) was ad-
ministered to ﬂies in the food. DUBs-IN-2 (or DMSO) was diluted in
water to the desired concentration and used to reconstitute dry
Formula 4-24 Instant Drosophila Medium (Carolina Biological
Supply). 1-d-old male mutant or control ﬂies in groups of 10 were
fed on the supplemented food for 48 h and subsequently climbing
assay was performed. In the case of DA neuron staining and
measurement of dopamine levels, mutant and control ﬂies were
aged for 15 d on the supplemented food that was exchanged every 2
d adding fresh drug or vehicle. The use of non-harmful food col-
oring demonstrated food uptake and excluded the possibility that
smell or taste of the drug prevented the latter. Toxic concentrations
were excluded beforehand by performing dose-dependent viability
curves on control ﬂies.
Drosophila head dopamine amount measurement (HPLC)
Drosophila heads of 15-d-old male ﬂies were dissected out and
collected separately in 10 μl of ice-cold 0.2 N perchloric acid. The
tissue was homogenized by sonication for 15 s and kept on ice for 20
min, then centrifuged at 12,000 g for 10 min, and the supernatant
was collected. The samples were further diluted and 5 μl was in-
jected into a HPLC system equipped with a rheodyne injector and a
guard cell, set to +350 mV (E1 = +150 mV, E2 = −350 mV, s: 2 nA). A C18
ion-pair, reverse phase analytical column (4.6 × 250 mm; 5 μm
particle size; Agilent Technologies) was used for the separation of
biogenic amines with a ﬂow rate of 0.8 ml/min. Composition of the
mobile phase was 75 mM sodium phosphate monobasic mono-
hydrate, 6% acetonitrile, 1.7 mM 1-octane sulfonic acid, and 25 μM
EDTA (pH 3 ± 0.01). Dopamine values were determined by comparing
with the standard peak value.
Electron microscopy
Thoraces were prepared from 3-d-old adult ﬂies and ﬁxed over-
night in 2% paraformaldehyde and 2.5% gluteraldehyde. After
rinsing in 0.1 M cacodylate buffer with 1% tannic acid, the samples
were postﬁxed in 1:1 2% OsO4 and 0.2 M cacodylate buffer for 1 h. The
samples were rinsed, dehydrated in an ethanol series, and
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embedded using Epon. Ultrathin sections were examined using a
transmission electron microscope.
Life span analysis
Male ﬂies of the indicated genotypes were collected during 12 h
after hatching and grouped into 20 ﬂies per food vial. At least 100
ﬂies were used for the analysis (exact numbers are indicated in the
ﬁgure legends). The ﬂies were transferred to fresh food (and fresh
drug for the inhibitor treatment) every 2 d, and dead ﬂies were
counted in the same interval.
Measurement of food uptake
Dry Formula 4-24 Instant Drosophila Medium (Carolina Biological
Supply) was reconstituted with a mix of water and food-coloring
patent blue V (E131) (1:1) previously supplemented with DMSO or the
desired DUBs-IN-2 concentration. Three groups of 10 male 1–3-d-
old w1118 ﬂies were kept in the food vials for 48 h. Afterward, the
ﬂies were weighed and homogenized in 20 volumes of PBS with an
electric potter. The homogenate was centrifuged for 10 min at
15.000 g and absorbance of the supernatant was measured at
640 nm.
BN PAGE
Pellets of mitochondria isolated from adult male ﬂies of the in-
dicated genotypes were suspended at 10mg ×ml−1 in 1× native PAGE
sample buffer (Invitrogen) supplemented with protease inhibitor
mixture (Sigma-Aldrich), solubilized with 2% (wt/vol) digitonin and
immediately centrifuged at 100,000 g for 25 min at 4°C. The
supernatants were supplemented with native PAGE 5% G-250
sample additive (Invitrogen) and quickly loaded onto a blue native
polyacrylamide 3–12% gradient gel (Invitrogen). After electropho-
resis, the gels were ﬁxed in 50% methanol + 10% acetic acid for 20
min at RT, stained in 0,025% Coomassie + 10% acetic acid overnight
at RT and destained with 10% acetic acid.
Sperm content and reproductive apparatus viability assay
The anatomy of male reproductive apparatus was analyzed on 10
males per group. To this aim, the reproductive apparatus was re-
moved, placed on a slide with few drops of Drosophila Ringer’s
solution (182 mM KCl, 46 mM NaCl, 3 mM CaCl2 2H2O, and 10 mM
Tris–HCl, pH 7.2) and freshly examined under a light microscope. To
verify the presence of sperm inside the seminal vesicles, these were
then removed from the whole apparatus and gently punctured with
a needle to let the sperm pouring out. Five more intact apparatuses
per group were stained with a dead/alive cell viability kit (Molecular
Probes) that allows differentiation between live green cells, per-
meable to green SYBR 14 nucleic acid stain, and red dead cells,
permeable to propidium iodide nucleic acid stain, which penetrates
through compromised membranes.
Statistical analysis
Where multiple groups were compared, statistical signiﬁcance was
calculated by one-way or two-way ANOVA with a post hoc Tukey or
Dunett correction. All statistical signiﬁcance was calculated at P =
0.05, using GraphPad Prism 8. For all the analysis, the samples were
collected and processed simultaneously and, therefore, no ran-
domization was appropriate (GraphPad Prism. ****P < 0.0001, ***P <
0.001, **P < 0.01, and *P < 0.05). Please refer to the enclosed
document for detailed statistical tests.
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
201900392.
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